Small-cell neuroendocrine carcinoma of the uterine cervix (SCCC), a rare but malignant cervical neoplasm, has a highly aggressive phenotype that requires more intensive treatment than other cervical tumors. Immunohistochemical methods were used to compare the expression of p21Cip1/Waf1 and p27Kip1 in SCCC and squamous cell carcinoma, the most common type of cervical cancer. In SCCC, p21 expression was significantly reduced compared with squamous cell carcinoma, whereas expression of p27 was similar in both carcinomas. Reduced expression of p21 could be a helpful diagnostic marker and may contribute to the invasive phenotype of SCCC.
Viswanathan AN, Deavers MT, Jhingran A., Ramirez PT, Levenback C., Eifel PJSmall cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence. Gynecol Oncol.2004;93:27-33.
2.
Tsunoda S., Jobo T., Arai M., et al. Small-cell carcinoma of the uterine cervix: a clinicopathologic study of 11 cases. Int J Gynecol Cancer. 2005 ;15:295-300.
3.
Wang HL, Lu DWDetection of human papillomavirus DNA and expression of p16, Rb, and p53 proteins in small cell carcinomas of the uterine cervix. Am J Surg Pathol.2004;28:901-908.
4.
Stoler MHHuman papillomaviruses and cervical neoplasia: a model for carcinogenesis . Int J Gynecol Pathol.2000;19:16-28.
5.
Jeon S., Lambert PFIntegration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis . Proc Natl Acad Sci U S A. 1995;92:1654-1658.
6.
Li Y., Nichols MA, Shay JW, Xiong Y.Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb. Cancer Res.1994;54:6078-6082.
7.
Coqueret O.New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment?Trends Cell Biol.2003;13:65-70.
8.
LaBaer J. , Garrett MD, Stevenson LF, et al. New functional activities for the p21 family of CDK inhibitors. Genes Dev.1997 ;11:847-862.
9.
Cheng M., Olivier P., Diehl JA, et al. The p21Cip1 and p27Kip1 CDK “inhibitors” are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J.1999;19:2168-2180.
10.
Macaluso M. , Montanari M., Cinti C., Giordano A.Modulation of cell cycle components by epigenetic and genetic events. Semin Oncol.2005;32:452-457.
11.
Werness BA, Wang HQ, Chance J., Goldstein DJp53independent expression of p21waf1/cip1 in preinvasive and invasive squamous neoplasms of the uterine cervix. Mod Pathol. 1997;10:578-584.
12.
Kim YT, Cho NH, Park SW, Kim JWUnderexpression of cyclin-dependent kinase (CDK) inhibitors in cervical carcinoma . Gynecol Oncol.1998;71:38-45.
13.
Skomedal H. , Kristensen GB, Lie AK, Holm R.Aberrant expression of the cell cycle associated proteins TP53, MDM2, p21, p27, cdk4, cyclin D1, RB, and EGFR in cervical carcinomas . Gynecol Oncol.1999;73:223-228.
14.
Bae DS, Cho SB, Kim YJ, et al. Aberrant expression of cyclin D1 is associated with poor prognosis in early stage cervical cancer of the uterus. Gynecol Oncol.2001;81: 341-347.
15.
Lu X., Toki T., Konishi I., Nikaido T., Fujii S.Expression of p21WAF1/CIP1 in adenocarcinoma of the uterine cervix. A possible immunohistochemical marker of a favorable prognosis. Cancer . 1998;82:2409-2417.
Wakasugi E. , Kobayashi T., Tamaki Y., et al. p21Waf1/Cip1 and p53 protein expression in breast cancer. Am J Clin Pathol.1997;107:684-691.
18.
Karjalainen JM, Eskelinen MJ, Kellokoski JK, Reinikainen M., Alhava EM, Kosma VMp21WAF1/CIP1 expression in stage I cutaneous malignant melanoma: its relationship with p53, cell proliferation and survival . Br J Cancer.1999;79:895-902.
19.
Li X., Hui AM, Shi YZ, Sun L., Takayama T., Makuuchi M.Deregulation of G1/S transition is a common event in carcinoma of the ampulla of Vater. Hepatogastroenterology. 2002;49:1239-1244.
20.
Okudela K., Ito T., Nakamura N., Kitamura H.Immunohistochemical analysis for cell proliferation-related protein expression in small cell carcinoma of the esophagus: a comparative study with small cell carcinoma of the lung and squamous cell carcinoma of the esophagus. Histol Histopathol. 1999;14:479-485.
21.
Yatabe Y., Masuda A., Koshikawa T., et al. p27KIP1 in human lung cancers: differential changes in small cell and non-small cell carcinomas. Cancer Res.1998;58:1042-1047.
22.
Masuda A., Osada H., Yatabe Y., et al. Protective function of p27KIP1 against apoptosis in small cell lung cancer cells in unfavorable microenvironments. Am J Pathol.2001;158:87-96.
23.
Hoskins PJ, Swenerton KD, Pike JA, et al. Small cell carcinoma of the cervix: fourteen years of experience at a single institution using a combined-modality regimen of involved-field irradiation and platinum-based combination chemotherapy. J Clin Oncol.2003;21:3495-3501.
